Nippon Hoechst Marion Roussel Closing Half Its Plants

10 November 1997

The Nippon Hoechst Marion Rossel group is currently in the process ofshutting down half of its six manufacturing plants in Japan. The facilities are run by three group affiliates and will close by early next year, according to the Nihon Industrial Daily.

Merger Planned The downsizing is in line with the parent company's strategy of improving productivity by combining manufacturing operations ahead of a planned merger of the three companies which set up Nippon HMR in 1976; Hoechst Japan, Marion Merrell Dow KK, Nippon Roussel KK and Roussel Morishita.

The company has already closed its Ibaraki plant and is to close its facility in Osaka by year-end. The plant, in Shiga, is expected to be shut down early next year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight